; (iii) is developed in and authorized by a State that has notified the Secretary of Health and Human Services of its intention to review tests intended to diagnose COVID–19; or (iv) is another test that the Secretary determines appropriate in guidance. (4) Covid–19 pandemic The term COVID–19 pandemic means the period beginning on the date of enactment of this Act and ending on the date that is 1 year after the date on which the public health emergency declaration under section 319 of the Public Health Service Act ( 42 U.S.C. 247d ) with respect to COVID–19 terminates. (5) High-risk incarcerated person The term high-risk incarcerated person means an individual who meets the definition of incarcerated person under this section who— (A) is 50 years old or older; (B) has chronic kidney disease; (C) has chronic obstructive pulmonary disease; (D) is immunocompromised; (E) has obesity; (F) has a heart condition, such as coronary artery disease or cardiomyopathy; (G) has sickle cell disease; (H) has type 1 or type 2 diabetes mellitus; (I) has moderate to severe asthma; (J) has cerebrovascular disease; (K) has cystic fibrosis; (L) has hypertension or high blood pressure; (M) has a neurological condition such as dementia or Parkinson’s Disease; (N) has liver disease; (O) is pregnant; (P) has pulmonary fibrosis; (Q) has thalassemia; (R) is a smoker; (S) has a disability